Summary
Development of a high-performance, reduced-cost Optical Coherence Tomography (OCT) otoscope for improved diagnosis of tympanic membrane and middle ear pathologies, aiming for a prototype commercial device.
Development of a high performance reduced cost OCT Otoscope
US · IL
NIH
grant
awarded
#nih-1R41DC022812-01
What they want
Redevelop an existing handheld OCT otoscope prototype into a commercial device, incorporating design improvements and cost-saving measures to reduce material costs by 44%. The new device will then be validated against the most recent research device to ensure similar or better performance in healthy volunteers and patients with tympanic membrane and/or middle ear pathology.
Deliverables
- Prototype commercial OCT otoscope
- Validation data/results comparing new device performance to research device
Technical requirements
- Handheld OCT otoscope
- Wide field of view (covering almost entire TM)
- Faster line rates to reduce motion artifact
- 44% reduction in overall materials cost
- Similar or better performance compared to the research device
Market context
inferred from NAICSManufacturing (heavy industrial, defense)
NAICS 339112
- US market size
- $2.5T
- Typical award
- $100K – $500M+
Typical buyers
DoDDLANASA
Commonly required
ISO 9001AS9100ITARCMMC L2+
Sector-level estimate — full code lookup not yet in catalog.
